Stephen D. Collins
Direttore/Membro del Consiglio presso Xalud Therapeutics, Inc.
Provenienza dei contatti di primo grado di Stephen D. Collins
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA.
9
| Subsidiary | Biotechnology | 9 |
Cerebral Therapeutics, Inc.
 Cerebral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
4
| Extinct | Financial Conglomerates | 4 |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ.
3
| Subsidiary | Biotechnology | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stephen D. Collins tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Chief Executive Officer Private Equity Investor Chief Executive Officer | |
Tevard Biosciences, Inc.
 Tevard Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Tevard Biosciences, Inc. is a biotechnology company based in Cambridge, MA. Tevard Biosciences is focused on developing trna-based and other modulating therapies to cure a broad range of genetic diseases. The company is advancing the use of its novel suppressor trna, enhancer trna, and mrna amplifier platforms in neurological disorders, heart disease, and muscular dystrophies. The company was founded in 2017 by Warren Burt Lammert, Harvey F. Lodish, Daniel Fischer, and Jeffrey Coller. Daniel Fischer has been the CEO since 2017. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
| VERRICA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Chief Operating Officer Director/Board Member | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree Doctorate Degree | |
| SAB BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| CANDEL THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Receptor Life Sciences, Inc.
 Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biscayne Pharmaceuticals, Inc.
 Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Biscayne Pharmaceuticals, Inc. develops drugs and pharmaceutical products. It offers drugs for CNS disorders such as refractory epilepsy and drug-resistant cancer. The firm also provides cancer therapies that block growth hormone-releasing hormone (GHRH) receptors. The company was founded by Andrew V. Schally and Samuel J. Reich in 2012 and is headquartered in Miami, FL. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Yale University | College/University | Undergraduate Degree Graduate Degree | |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Food: Meat/Fish/Dairy | Chief Executive Officer Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| Rollins College (Florida) | College/University | Undergraduate Degree | |
| PRECIGEN, INC. | Biotechnology | Private Equity Investor | |
Benevolent Capital Partners LLC (Private Equity)
 Benevolent Capital Partners LLC (Private Equity) Investment ManagersFinance Benevolent Capital Partners LLC (Private Equity) (Benevolent Capital) is a private equity and venture capital firm founded in 2005 by Brett M. Johnson and Grant D. Johnson. The firm is headquartered in Charlottesville, Virginia. | Investment Managers | Founder | |
| Octagon Partners LLC | Corporate Officer/Principal | ||
| Ravelin Capital Group LLC | Corporate Officer/Principal | ||
NatWest Markets Securities, Inc.
 NatWest Markets Securities, Inc. Investment Banks/BrokersFinance Founded in 1985, NatWest Markets Securities, Inc. is a financial services and brokerage firm headquartered in Stamford, Connecticut. The firm is a subsidiary of RBS Holdings USA, Inc. and their ultimate parent is the Royal Bank of Scotland Plc (LSE: RBS). The firm was formerly known as RBS Securities, Inc., RBS Greenwich Capital, and Greenwich Capital Markets, Inc. NatWest is an institutional fixed-income firm that provides a full range of debt capital markets services to both those seeking to raise capital and those seeking to invest it. The firm is an industry leader in the U.S. Treasury, agency and MBS markets and in providing real estate and asset-backed financing to their clients. NatWest also provides futures brokerage services and trade strategies to select clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
| CS First Boston Pacific, Inc. | Corporate Officer/Principal | ||
Enterprise Mortgage Acceptance Co. LLC
 Enterprise Mortgage Acceptance Co. LLC Miscellaneous Commercial ServicesCommercial Services Enterprise Mortgage Acceptance Co. LLC provides capital and financing options for equipment financing and business loans. The private company is based in Westport, CT and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
| LYTIX BIOPHARMA | Pharmaceuticals: Major | Director/Board Member | |
| The University of Pennsylvania Law School | College/University | Graduate Degree | |
RareGen LLC
 RareGen LLC Miscellaneous Commercial ServicesCommercial Services RareGen LLC provides strategy, investment, and commercialization for rare disease pharmaceutical products. The company is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
| Beta-Pro LLC | Corporate Officer/Principal | ||
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| ADVANZ PHARMA CORP. LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Foundation Fighting Blindness Clinical Research Institute
 Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Financial Conglomerates | Director/Board Member | |
UVA Health Foundation
 UVA Health Foundation Internet Software/ServicesTechnology Services Part of University of Virginia, UVA Health Foundation operates a healthcare platform. The company is based in Charlottesville, VA. | Internet Software/Services | Director/Board Member | |
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Director/Board Member | |
ArcherDX LLC
 ArcherDX LLC Packaged SoftwareTechnology Services ArcherDX LLC is a genomic analysis company, which develops software solutions for investigating cancer treatment. Its products include VariantPlex, FusionPlex, LiquidPlex, reveal ctDNA, Immunoverse, custom assays, and archer analysis. The company was founded by Jason W. Myers, A. John Iafrate, and Long Phi Le on January 1, 2013 and is headquartered in Boulder, CO. | Packaged Software | Director/Board Member | |
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| University of Colorado Health Sciences Center | College/University | Corporate Officer/Principal | |
PatientsLikeMe LLC
 PatientsLikeMe LLC Internet Software/ServicesTechnology Services PatientsLikeMe LLC operates online health communities for patients. The firm offers data and information on patients, treatments, symptoms and research. The company was founded by Benjamin Heywood, James Heywood and Jeff Cole in 2004 and is headquartered in Cambridge, MA. | Internet Software/Services | Director/Board Member | |
University of Virginia Community Credit Union
 University of Virginia Community Credit Union Savings BanksFinance University of Virginia Community Credit Union operates as a state chartered credit union. The private company is based in Charlottesville, VA and has subsidiaries in the United States. | Savings Banks | Corporate Officer/Principal | |
| Pbm Capital Investments LLC | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Norvegia | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 22 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 7 |
| Technology Services | 4 |
Posizioni
| Director/Board Member | 139 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 27 |
| Founder | 24 |
| Chairman | 21 |
Contatti più connessi
| Insiders | |
|---|---|
| Mahendra Shah | 34 |
| Sean Stalfort | 28 |
| Paul Manning | 26 |
| Gerry Brunk | 25 |
| Stephen Farr | 16 |
| Orrin Devinsky | 16 |
| Timothy Scannell | 14 |
| Matthew Hammond | 13 |
| James Martin | 13 |
| Jeffrey Spragens | 13 |
| Warren Lammert | 12 |
| John Foster | 11 |
| Jayson M. Rieger | 10 |
| Samuel Reich | 9 |
| Ilan Katz | 7 |
- Borsa valori
- Insiders
- Stephen D. Collins
- Connessioni Società
